Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological, and otological studies of heterozygous KO mice
- 6 November 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 325 (4) , 1163-1171
- https://doi.org/10.1016/j.bbrc.2004.10.147
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A Point Mutation in the Motor Domain of Nonmuscle Myosin II-B Impairs Migration of Distinct Groups of NeuronsMolecular Biology of the Cell, 2004
- Cloning and developmental expression of nonmuscle myosin IIA (Myh9) in the mammalian inner earJournal of Neuroscience Research, 2004
- Ablation and Mutation of Nonmuscle Myosin Heavy Chain II-B Results in a Defect in Cardiac Myocyte CytokinesisCirculation Research, 2003
- Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 geneHuman Genetics, 2001
- Identification of six novel MYH9 mutations and genotype–phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusionsJournal of Human Genetics, 2001
- Nonmuscle Myosin Heavy Chain IIA Mutations Define a Spectrum of Autosomal Dominant Macrothrombocytopenias: May-Hegglin Anomaly and Fechtner, Sebastian, Epstein, and Alport-Like SyndromesAmerican Journal of Human Genetics, 2001
- Mutations in the NMMHC-A gene cause autosomal dominant macrothrombocytopenia with leukocyte inclusions (May-Hegglin anomaly/Sebastian syndrome)Blood, 2001
- Alport Disease: A Review of the Diagnostic DifficultiesUltrastructural Pathology, 2001
- Characterization of the Human and Mouse Unconventional Myosin XV Genes Responsible for Hereditary Deafness DFNB3 and Shaker 2Genomics, 1999
- Effects of shaker-1 mutations on myosin-VIIa protein and mRNA expressionCell Motility, 1997